National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 64360-64361 [2011-26928]
Download as PDF
mstockstill on DSK4VPTVN1PROD with NOTICES
64360
Federal Register / Vol. 76, No. 201 / Tuesday, October 18, 2011 / Notices
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Chemistry, Biochemistry, Biophysics, and
Bioengineering.
Date: November 14–15, 2011.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ross D. Shonat, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6172,
MSC 7892, Bethesda, MD 20892, 301–435–
2786, ross.shonat@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Cystic Fibrosis, Cystic Lung
Disease.
Date: November 14, 2011.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Everett E. Sinnett, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1016, sinnett@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR09–129:
MLPCN High Throughput Screening Assays
for Drug Discovery.
Date: November 15, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Ping Fan, MD, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Nephrology.
Date: November 15–16, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications,
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Atul Sahai, PhD, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 2188, MSC 7818, Bethesda, MD
20892, 301–435–1198, sahaia@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Mar<15>2010
18:59 Oct 17, 2011
Jkt 223001
Dated: October 12, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26941 Filed 10–17–11; 8:45 am]
BILLING CODE 4140–01–P
Neurosciences, National Institutes of Health,
HHS)
Dated: October 12, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26930 Filed 10–17–11; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Neurological
Disorders and Stroke Notice of Closed
Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders B.
Date: October 20, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Spa and Hotel, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Ernest W. Lyons, PhD,
Scientific Review Officer, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard,
MSC 9529, Neuroscience Center, Room 3208,
Bethesda, MD 20892, 301–496–4056.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders K.
Date: November 4, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Shanta Rajaram, PhD,
Scientific Review Officer, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard,
MSC 9529, Neuroscience Center, Room 3208,
Bethesda, MD 20892, 301–435–6033,
rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Virtual Reality Technologies for Research
and Education in Obesity and Diabetes.
Date: November 7, 2011.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: David A. Wilson, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Virtual Reality Technologies for Research
and Education in Obesity and Diabetes.
Date: November 7, 2011.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: David A. Wilson, PhD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
E:\FR\FM\18OCN1.SGM
18OCN1
Federal Register / Vol. 76, No. 201 / Tuesday, October 18, 2011 / Notices
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 12, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–26928 Filed 10–17–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2011–0029; OMB No.
1660–0095]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; National Flood
Insurance Program Claims Appeals
Process
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
The Federal Emergency
Management Agency, as part of its
continuing effort to reduce paperwork
and respondent burden, invites the
general public and other Federal
agencies to take this opportunity to
comment on a proposed revision of a
currently approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
notice seeks comments concerning
revision of the National Flood Insurance
Claims Appeals Process. The appeal
process establishes a formal mechanism
to allow policyholders to appeal the
decisions of any insurance agent,
adjuster, insurance company, or any
FEMA employee or contractor, in cases
or unsatisfactory decisions on claims,
proof of loss, and loss estimates.
Under this process, FEMA sends the
NFIP Flood Insurance Claims Handbook
to the policyholder (upon completion of
signed policy), which explains to them
the appeals process. If the policyholder
wishes to appeal a claims decision, that
policyholder may appeal it to FEMA.
FEMA will acknowledge receipt of a
policyholder’s appeal in writing and
advise such policyholder if additional
information is required in order to fully
consider the appeal. FEMA will review
the documentation submitted by the
policyholder, conduct any necessary
additional investigation, and advise,
both the policyholder and the
appropriate flood insurance carrier, of
its decision regarding the appeal.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:46 Oct 17, 2011
Jkt 226001
Comments must be submitted on
or before December 19, 2011.
ADDRESSES: To avoid duplicate
submissions to the docket, please use
only one of the following means to
submit comments:
(1) Online. Submit comments at
https://www.regulations.gov under
Docket ID FEMA–2011–0029. Follow
the instructions for submitting
comments.
(2) Mail. Submit written comments to
Docket Manager, Office of Chief
Counsel, DHS/FEMA, 500 C Street, SW.,
Room 835, Washington, DC 20472–
3100.
(3) Facsimile. Submit comments to
(703) 483–2999.
(4) E-mail. Submit comments to
FEMA-POLICY@dhs.gov. Include Docket
ID FEMA–2011–0029 in the subject line.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy Act notice that is available via
the link in the footer of https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Dennis Kuhns, Division Director, Risk
Insurance Division, 202–212–0429 for
additional information. You may
contact the Records Management
Division for copies of the proposed
collection of information at facsimile
number (202) 646–3347 or e-mail
address: FEMA-Information-CollectionsManagement@dhs.gov.
SUPPLEMENTARY INFORMATION: Section
205 of The Bunning-BereuterBlumenauer Flood Insurance Reform
Act of 2004, Public Law 108–264
Section 205, 42 U.S.C. 4011 note,
requires the Federal Emergency
Management Agency to establish by
regulation an additional process for the
appeal of decisions of flood insurance
claims issued through the National
Flood Insurance Program. FEMA’s
regulation at 44 CFR 62.20 details the
appeals process.
The process requires policyholders to
submit a written appeal to the Federal
Emergency Management Agency
(Mitigation Directorate/Risk Insurance
Division), in the form of a signed letter
explaining the nature of their claim
appeal, names and titles of persons
contacted, dates of contact, contact
information, and details of the contact
relevant to their claim appeal. These
DATES:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
64361
requirements are spelled out to
policyholders in the aforementioned
NFIP Flood Insurance Claims
Handbook. The policyholders are also
required to state the basis for their
appeal and submit supporting
documentation including a copy of the
insurer’s written denial, in whole or in
part, of the claim.
Collection of Information
Title: National Flood Insurance
Program Claims Appeals Process.
Type of Information Collection:
Revision of a currently approved
information collection.
OMB Number: 1660–0095.
Form Titles and Numbers: None.
Abstract: The NFIP claims appeals
process requires policyholders to submit
a written appeal to the Federal
Emergency Management Agency
(Mitigation Directorate/Risk Insurance
Division), in the form of a signed letter
explaining the nature of their claim
appeal, names and titles of persons
contacted, dates of contact, contact
information, and details of the contact
relevant to their claim appeal. The
policyholders are also required to state
the basis for their appeal and submit
supporting documentation including a
copy of the insurer’s written denial, in
whole or in part, of the claim.
Affected Public: Individuals or
households and Business or other-forprofits.
Estimated Total Annual Burden
Hours: 2110 hours.
Estimated Cost: The cost to
policyholders would be an annual cost
of $464.20 for postage.
Comments
Comments may be submitted as
indicated in the ADDRESSES caption
above. Comments are solicited to (a)
evaluate whether the proposed data
collection is necessary for the proper
performance of the agency, including
whether the information shall have
practical utility; (b) evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) enhance the quality, utility, and
clarity of the information to be
collected; and (d) minimize the burden
of the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
E:\FR\FM\18OCN1.SGM
18OCN1
Agencies
[Federal Register Volume 76, Number 201 (Tuesday, October 18, 2011)]
[Notices]
[Pages 64360-64361]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-26928]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Virtual Reality Technologies for Research
and Education in Obesity and Diabetes.
Date: November 7, 2011.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate grant applications.
Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: David A. Wilson, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892-7924,
301-435-0299, wilsonda2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Virtual Reality Technologies for Research
and Education in Obesity and Diabetes.
Date: November 7, 2011.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: David A. Wilson, PhD, Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892-7924,
301-435-0299, wilsonda2@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
[[Page 64361]]
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 12, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-26928 Filed 10-17-11; 8:45 am]
BILLING CODE 4140-01-P